Aldeyra Therapeutics (ALDX) Return on Capital Employed Growth (1y) (2015 - 2026)
Aldeyra Therapeutics (ALDX) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 2,400.00 |
| 10 | Aldeyra Therapeutics | 94.70 Mn | 94.70 Mn | - | 911.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 911.00 |
| Dec 31, 2025 | -975.00 |
| Sep 30, 2025 | -3,791.00 |
| Jun 30, 2025 | -4,894.00 |
| Mar 31, 2025 | -4,353.00 |
| Dec 31, 2024 | -3,100.00 |
| Sep 30, 2024 | -867.00 |
| Jun 30, 2024 | -256.00 |
| Mar 31, 2024 | 1,095.00 |
| Dec 31, 2023 | 276.00 |
| Sep 30, 2023 | -120.00 |
| Jun 30, 2023 | -477.00 |
| Mar 31, 2023 | -1,044.00 |
| Dec 31, 2022 | -1,223.00 |
| Sep 30, 2022 | -1,590.00 |
| Jun 30, 2022 | -1,008.00 |
| Mar 31, 2022 | 684.00 |
| Dec 31, 2021 | 2,499.00 |
| Sep 30, 2021 | 3,001.00 |
| Jun 30, 2021 | 5,480.00 |